We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

A blood-based DNA methylation approach flags prostate cancer risk 5–8 years early and stratifies breast cancer risk. More...
24 Sep 2026
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

A new urine test measures 31 mycotoxin markers using LC-MS/MS and hydrolysis to reveal masked metabolites, aiding diagnosis. More...
24 Sep 2026
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to support earlier Alzheimer’s and dementia diagnosis in the UK. More...
24 Sep 2026
Image: The proposed workflow adds liquid biopsy to detect genetic and molecular signs of cancer in CSF samples already collected during autoimmune encephalitis evaluation. (Image Credit: Shutterstock)

CSF Liquid Biopsy Could Help Distinguish Cancer from Autoimmune Brain Inflammation

Adding a cerebrospinal fluid liquid biopsy to autoimmune encephalitis evaluations could help detect hidden brain cancers. More...
24 Sep 2026
Image: Vaginal and urine samples showing endometrial cancer (true positive case; upper row) and no malignant cells (true negative case; lower row). (Jones ER, Narine N, O\'Flynn H, et al. The Lancet Obstetrics, Gynaecology, & Women\'s Health (2026). DOI:10.1016/S3050-5038(26)00222-0.)

Simple Test Could Reduce the Need for Invasive Uterine Cancer Checks

Combined urine and vaginal cytology helps triage postmenopausal bleeding, detecting over 80% of cancers with 98.8% NPV. More...
24 Sep 2026
Image: Galleri is designed to detect cancer-specific methylation patterns across multiple cancer types before symptoms appear, including cancers without recommended screening (Photo courtesy of GRAIL)

Multi-Cancer Early Detection Test Wins FDA Panel Backing for Approval

GRAIL’s Galleri MCED test received a favorable FDA advisory panel vote supporting its Premarket Approval (PMA) application. More...
24 Sep 2026
Image: Galleri is designed to detect cancer-specific methylation patterns across multiple cancer types before symptoms appear, including cancers without recommended screening (Photo courtesy of GRAIL)

Multi-Cancer Early Detection Test Wins FDA Panel Backing for Approval

GRAIL’s Galleri MCED test received a favorable FDA advisory panel vote supporting its Premarket Approval (PMA) application. More...
24 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Urine Analyzer
respons® UDS100
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Copyright © 2000-2026 Globetech Media. All rights reserved.